Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Cash And Cash Equivalents
$5,407 Mil (As of Jun. 2014)

GlaxoSmithKline PLC's quarterly cash and cash equivalents declined from Dec. 2013 ($9,117 Mil) to Mar. 2014 ($5,886 Mil) and declined from Mar. 2014 ($5,886 Mil) to Jun. 2014 ($5,407 Mil).

GlaxoSmithKline PLC's annual cash and cash equivalents declined from Dec. 2011 ($8,873 Mil) to Dec. 2012 ($6,684 Mil) but then increased from Dec. 2012 ($6,684 Mil) to Dec. 2013 ($9,117 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 4,6357,4483,9306,6588,12610,5749,5548,8736,6849,117

GlaxoSmithKline PLC Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
BS_CashAndCashEquivalents 9,01811,5275,4526,6845,8684,3115,2379,1175,8865,407
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide